Procter & Gamble (PG)

Cash & Short-Term Investments

$15.37B

Quarterly · Period ending: · USD

PG logo

PG Cash & Short-Term Investments

Latest reported$15.37B
PG Quarterly Cash & Short-Term Investments ($565.00M → $15.37B)
High-resolution chart · PNG

PG cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Procter & Gamble Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
15,365,000,000
9,942,000,000
12,306,000,000
10,825,000,000
11,171,000,000
9,556,000,000
9,116,000,000
10,230,000,000
12,156,000,000
9,482,000,000
6,828,000,000
7,890,000,000
9,733,000,000
8,246,000,000
7,596,000,000
6,854,000,000
6,710,000,000
7,214,000,000
8,526,000,000
11,544,000,000
10,370,000,000
10,288,000,000
10,007,000,000
11,941,000,000
13,392,000,000
16,181,000,000
15,393,000,000
6,279,000,000
9,304,000,000
10,287,000,000
9,823,000,000
12,117,000,000
11,253,000,000
11,850,000,000
15,534,000,000
18,758,000,000
16,007,000,000
15,137,000,000
14,327,000,000
13,454,000,000
14,071,000,000
13,348,000,000
13,819,000,000
14,277,000,000
12,606,000,000
11,603,000,000
13,160,000,000
12,251,000,000
10,846,000,000
10,686,000,000
9,752,000,000
8,503,000,000
7,702,000,000
5,947,000,000
5,876,000,000
6,643,000,000
5,302,000,000
4,436,000,000
3,991,000,000
4,414,000,000
3,582,000,000
2,768,000,000
2,946,000,000
3,249,000,000
2,603,000,000
2,879,000,000
4,899,000,000
4,130,000,000
6,294,000,000
4,781,000,000
4,434,000,000
5,653,000,000
4,502,000,000
3,313,000,000
4,078,000,000
6,045,000,000
4,997,000,000
5,556,000,000
4,230,000,000
5,508,000,000
7,758,000,000
7,826,000,000
10,199,000,000
9,812,000,000
8,059,000,000
8,133,000,000
8,778,000,000
8,170,000,000
6,718,000,000
5,892,000,000
5,750,000,000
5,294,000,000
4,379,000,000
6,212,000,000
5,825,000,000
5,324,000,000
4,889,000,000
3,623,000,000
3,531,000,000
3,396,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.